Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
11
|
| pubmed:dateCreated |
1997-7-10
|
| pubmed:abstractText |
CD44 is a family of molecules involved in cell-cell and cell-matrix interactions. Various isoforms of CD44 arise by insertion of one or more of the variant exons into the common backbone shared by all forms of CD44. In this work, we studied the expression of CD44 and exon v6-containing CD44 isoforms (CD44v6) in several nonmalignant and malignant conditions and the possibilities for regulating the expression of CD44v6. In primary squamocellular carcinomas of the head and neck, CD44 and CD44v6 were down-regulated in poorly differentiated tumors, whereas these molecules were uniformly expressed in the normal squamocellular epithelium, in proliferating skin diseases, and in nonmalignant tumors. When CD44v6 expression of original tumors and that of squamocellular carcinoma cell lines derived from them were compared, no CD44v6 up-regulation could be observed on in vitro growing cells. Moreover, several regulators were unable to up-regulate CD44v6 expression on cultured cell lines in vitro. When the same cell lines formed tumors after s.c. injection into severe combined immunodeficient mice, some of them up-regulated their CD44v6 expression. These data suggest that cell lines at certain differentiation stages can be induced to express CD44v6. Our results further indicate that CD44v6 positivity cannot be used as a universal indicator of tumor metastasis. Instead, the down-regulation of CD44v6 in squamocellular tumors is a sign of malignant transformation of the epithelium.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
0008-5472
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
1
|
| pubmed:volume |
57
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2281-9
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:9187133-Adult,
pubmed-meshheading:9187133-Aged,
pubmed-meshheading:9187133-Animals,
pubmed-meshheading:9187133-Antigens, CD44,
pubmed-meshheading:9187133-Carcinoma, Squamous Cell,
pubmed-meshheading:9187133-Down-Regulation,
pubmed-meshheading:9187133-Epithelium,
pubmed-meshheading:9187133-Exons,
pubmed-meshheading:9187133-Female,
pubmed-meshheading:9187133-Fluorescent Antibody Technique, Indirect,
pubmed-meshheading:9187133-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:9187133-Head and Neck Neoplasms,
pubmed-meshheading:9187133-Humans,
pubmed-meshheading:9187133-Immunohistochemistry,
pubmed-meshheading:9187133-Isomerism,
pubmed-meshheading:9187133-Male,
pubmed-meshheading:9187133-Mice,
pubmed-meshheading:9187133-Mice, SCID,
pubmed-meshheading:9187133-Middle Aged,
pubmed-meshheading:9187133-Skin Diseases,
pubmed-meshheading:9187133-Tumor Cells, Cultured,
pubmed-meshheading:9187133-Ultraviolet Rays,
pubmed-meshheading:9187133-Up-Regulation
|
| pubmed:year |
1997
|
| pubmed:articleTitle |
Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cells.
|
| pubmed:affiliation |
National Public Health Institute and MediCity Research Laboratory, Turku University, Finland.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|